BRIEF — Santhera Pharmaceuticals H1 Operating Income CHF — 6.562 Million
Sep 30 (Reuters) — Santhera Pharmaceuticals H1 operating expenses CHF -25.007 million. H1 net income CHF -21.526 million H1 EPS CHF -1.5
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sep 30 (Reuters) — Santhera Pharmaceuticals H1 operating expenses CHF -25.007 million. H1 net income CHF -21.526 million H1 EPS CHF -1.5